Roche Urges Illumina Shareholders To Spur $6B Merger

Law360, New York (March 20, 2012, 10:30 PM EDT) -- Roche Holding AG launched a new salvo Monday in its $5.7 billion hostile takeover bid for gene-sequencing firm Illumina Inc., asking Illumina investors to tender their shares and vote for new board members who will support the sale of the company.

"Do not let Illumina silence your voice," Roche CEO Severin Schwan wrote to Illumina shareholders in a letter sent one month before their April 18 meeting.

Roche, a leading developer of pharmaceuticals and diagnostics, went public in January with a $44.50-per-share bid for Illumina after...
To view the full article, register now.